In vitro effects of antifungal drugs on Candida albicans and phagocytic cell function

In vitro effects of antifungal drugs on Candida albicans and phagocytic cell function

Bibliographic Details
Main Author:	Johnson, E. M.
Published:	University of Bristol 1987
Subjects:	615.1 Azole antifungals study
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375031

Similar Items

Interaction of azole antifungal agents with mouse hepatic microsomal cytochromes P-450
by: Ballard, S. A.
Published: (1988)

Peptide transport in Candida albicans and synthetic antifungal agents
by: Shallow, David A.
Published: (1986)

Pyrimidine transport and salvage metabolism in pathogenic Candida
by: Fasoli, Marco Oldo
Published: (1989)

Drug targeting with phagocytic polymorphonuclear leucocytes
by: Hyde, Robert
Published: (1989)

The synthesis of novel #beta#-lactams with potential antifungal activity
by: Thomas, Russell John
Published: (1990)

Estudos de QSAR 2D baseados em descritores topológicos e fragmentos moleculares para uma série de derivados azólicos ativos contra Candida albicans
by: Jônathas G. Andrade, et al.
Published: (2012-01-01)

CORRELATE BETWEEN BIOFILM FORMATION AND AZOLE ANTIFUNGAL SUSCEPTIBILITY AGAINST PLANKTONIC AND SESSILE CANDIDA ALBICANS CLINICAL ISOLATES
by: Saira Salim, et al.
Published: (2021-06-01)

Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013
by: Lei Zhang, et al.
Published: (2015-04-01)

The effects of antifungal drugs in combination on the growth of Candida species
by: Siau, Hong
Published: (1992)

The effects of antimicrobial drugs on human polymorphonuclear neutrophil phagocytic and candidacidal function
by: Pallister, Christopher John
Published: (1996)

Peptide aptamer selection for antifungal drug discovery and diagnostics
by: Grice, Christopher Martin
Published: (2015)

Involvement of membrane sulphydryl groups in phagocyte activation
by: Jefferiss, Carolyn
Published: (1990)

In vitro antifungal susceptibility of oral candida species from Iranian HIV infected patients
by: Katiraee F, et al.
Published: (2012-05-01)

In vitro models to describe the pharmacokinetics and pharmacodynamics of new and existing antifungal agents
by: Box, H. J.
Published: (2017)

Antifungal Resistance Analysis of Environmental Isolates of Aspergillus in North India
by: Shanu Hoda, et al.
Published: (2019-03-01)

Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt
by: Amira M El-Ganiny, et al.
Published: (2021-03-01)

Species distribution and antifungal susceptibility pattern of Candida causing oral candidiasis among hospitalized patients
by: Faseela Taivalap Shafi, et al.
Published: (2015-01-01)

Synthesis and antifungal activity investigation of a novel clotrimazole derivative
by: B Zoljargal, et al.
Published: (2014-10-01)

Isolation and production of bioactive compounds from basidiomycetes
by: Vahidi, Hossein
Published: (1996)

The hepatic effects of ketoconazole
by: Thomson, Richard G.
Published: (1989)

Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
by: Antonio Vena, et al.
Published: (2020-02-01)

Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
by: Jingwen Tan, et al.
Published: (2021-05-01)

Reversal of azole resistance in Candida albicans by oridonin
by: Haisheng Chen, et al.
Published: (2021-03-01)

Antifungal resistance: current trends and future strategies to combat
by: Wiederhold NP
Published: (2017-08-01)

Antifungal agents: Polyene, azole, antimetabolite, other and future agents
by: Fardin Ali Malayeri, et al.
Published: (2018-03-01)

Role of Antifungal Combinations in Difficult to Treat <i>Candida</i> Infections
by: Roxana G. Vitale
Published: (2021-09-01)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
by: Mayr A, et al.
Published: (2011-04-01)

The effects of hormones, drugs and metabolites on amphibian tissues in vitro
by: Holmes, C. H.
Published: (1978)

Antifungal azole metabolites: Significance in pharmaceutical and biomedical analysis
by: Kokil Sachin, et al.
Published: (2009-01-01)

The penetration of mammalian phagocytes by antibiotics
by: Eltahawy, A. T. A. E.
Published: (1981)

Continual Decline in Azole Susceptibility Rates in Candida tropicalis Over a 9-Year Period in China
by: Yao Wang, et al.
Published: (2021-07-01)

Prediction of drug-drug interactions from in vitro data : impact of multiple inhibitors and inhibition mechanisms
by: Hinton, Laura K.
Published: (2008)

Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre
by: Lyn Awad, et al.
Published: (2018-11-01)

Susceptibility in vitro of clinical Candida albicans isolates to the selected azoles
by: Pawlicki Bartlomiej, et al.
Published: (2021-06-01)

Paediatric drug development : reformulation, in vitro, genomic and in vivo evaluation
by: Russell, Craig
Published: (2014)

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
by: Amir Arastehfar, et al.
Published: (2020-12-01)

The rational design of an antifungal nail lacquer using the Hansen Solubility Parameter concept
by: Hossin, B.
Published: (2015)

Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?
by: Sarah Berger, et al.
Published: (2017-06-01)

Prostaglandin Biosynthesis in Adipose Tissue and its Inhibition by Anti-Inflammatory Drugs in vitro
by: Chang, P. J. Y. H.
Published: (1977)

Development of novel proximal tubule in vitro models to predict drug-induced nephrotoxicity
by: Tort Piella, A.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_okjoh37ouu2e8dppkp8hn75uip